U.S. Metals and Mining Stock News

RadNet recently presented at the 2026 KeyBanc Capital Markets Healthcare Virtual Forum, where Executive VP and CFO Mark D. Stolper discussed financial performance following a fiscal update showing 14.8% year-on-year revenue growth and margins supported by strong procedural volumes. The company also raised its 2025 revenue and adjusted EBITDA guidance for its Imaging Center segment, underscoring how operational improvements and its growing artificial intelligence division are increasingly...

USA Rare Earth stock reacts to recent trading performance USA Rare Earth (USAR) has drawn attention after recent share price moves, including a 3.6% decline over the past day and a 5.0% drop over the past week, following strong performance over the past 3 months. See our latest analysis for USA Rare Earth. The recent 3.6% 1 day and 18.4% 30 day share price declines contrast with a 21.4% 90 day share price return and a very large 1 year total shareholder return of 159.2%. This suggests...

AngloGold Ashanti (NYSE:AU) has put its Arthur Gold Project in Nevada firmly on the radar by completing a pre-feasibility study that confirms sizeable gold and silver reserves, outlines a multi year mine plan, and presents detailed development blueprints. See our latest analysis for AngloGold Ashanti. The Arthur Gold Project update lands at a time when AngloGold Ashanti’s 1-year total shareholder return of 152.10% and 5-year total shareholder return of 334.59% contrast with a recent 30.21%...

Hertz Global Holdings (HTZ) is back in focus after a partial US government shutdown led to long airport security lines, which pushed more travelers to consider rental cars and increased interest in the stock. See our latest analysis for Hertz Global Holdings. The latest excitement around airport delays sits against a mixed record, with a 16.46% 7 day share price return contrasting with a 90 day share price return of negative 12.88% and a 3 year total shareholder return of negative 71.76%...

Madrigal Pharmaceuticals (NasdaqGS:MDGL) has entered an exclusive global licensing agreement with Suzhou Ribo Life Science and Ribocure. The deal covers six preclinical small interfering RNA programs and extends Madrigal's pipeline beyond its MASH therapy Rezdiffra. The companies expect to submit investigational new drug applications for the first siRNA candidates this year. Madrigal Pharmaceuticals is drawing fresh attention as it adds RNA based therapies to a portfolio that already...

If you are wondering whether National Bank Holdings at around US$37.94 is giving you enough value for the risk you are taking, this breakdown will help you put the current share price in context. The stock has returned 1.2% over the last 7 days, is down 5.1% over the past month, and is roughly flat year to date at 0.1%, while the 1 year and 3 year returns sit at 1.1% and 24.3% respectively. These recent moves come as investors continue to assess National Bank Holdings' position in the US...

Why Dana 2030 is in focus Dana (DAN) has put its new Dana 2030 plan at center stage after Capital Markets Day, linking long term revenue and margin goals with a sizable program of share repurchases and dividends. See our latest analysis for Dana. The Dana 2030 announcement lands after a sharp shift in sentiment, with a 35.74% 90 day share price return and a very large 152.45% 1 year total shareholder return signaling strong recent momentum. If Dana 2030 has you thinking about what else could...

Paul Mueller (MUEL) opened FY 2025 with third quarter revenue of US$61.4 million and EPS of US$5.25, while trailing twelve month revenue sat at US$263.3 million and EPS at US$34.90. These figures reflect the company’s move into consistent profitability over the past year. Revenue has ranged from US$58.9 million to US$72.6 million across the last six reported quarters, with quarterly EPS moving between US$5.25 and US$17.80, giving investors a clear view of how margins have settled into a more...

What recent performance says about EastGroup Properties EastGroup Properties (EGP) has drawn attention after recent share price moves, with a last close of $183.17 and mixed short term returns that include a roughly 7% decline over the past month. For longer term holders, the stock shows a total return of about 7% over the past year and around 21% over the past 3 months. This gives investors a useful snapshot of how the REIT has traded recently. See our latest analysis for EastGroup...

Magnite’s recent performance and what it means for investors Magnite (MGNI) has drawn investor attention after a period of weak share performance, with the stock showing negative returns over the past week, month, past 3 months and year to date. See our latest analysis for Magnite. At a share price of $11.65, Magnite’s weak recent share price returns over 1 day, 7 days, 30 days and 90 days suggest fading short term momentum, even though the 1 year and 3 year total shareholder returns remain...

If you are wondering whether Crescent Energy's current share price reflects its underlying value, it helps to step back and look at the full picture before making any decisions. The stock last closed at US$13.70, with recent returns of 8.1% over 7 days, 17.5% over 30 days, 61.0% year to date and 29.2% over 1 year. This performance has put Crescent Energy firmly on many investors' watchlists. These moves have come as Crescent Energy continues to attract attention within the energy sector,...

Rush Enterprises appointed longtime executive Jody Pollard as Chief Operating Officer, following the departure of Jason Wilder. The leadership change places Pollard in a central role overseeing operations and executing company initiatives. The appointment is relevant for investors watching how management transitions may influence execution and operational priorities. Rush Enterprises, listed as NasdaqGS:RUSH.A, is trading at $66.08, with the share price reflecting a 22.2% return year to...

On 24 March 2026, WEX Inc. launched a specialized Health Reimbursement Arrangement to let employers carve out GLP-1 drug coverage into a defined-contribution benefit, using its payments platform to set tailored funding and reimbursement rules. This offering targets the fiscal strain created by GLP-1 medications for the roughly 34 million Americans who medically qualify for these weight-management drugs, aiming to give employers clearer cost control while preserving access. Next, we’ll...

Kroger recently expanded Cold Case Ice Cream into more than 1,000 banner stores nationwide, invested over US$112 million in new and remodeled Ohio locations, and rolled out 4X Fuel Points events alongside price cuts to help customers manage rising fuel costs. Together, these moves highlight Kroger’s push to deepen regional store presence while using differentiated products and fuel rewards to reinforce customer loyalty. Next, we’ll examine how Kroger’s US$112 million Ohio store investment...

This article examines whether Fortinet, at around US$78 a share, still offers value or if most of the upside may already be reflected in the price, by looking at what the current market valuation might be implying. The stock has had a mixed run, with a 3.9% decline over the last 7 days and a 1.1% decline over the last 30 days, while the 1 year return sits at a 19.0% loss and the 3 and 5 year returns stand at 17.7% and 109.8% respectively. Recent attention on Fortinet has been influenced by...

CoStar Group (NasdaqGS:CSGP) has appointed Nana Banerjee as an Independent Director to its Board. Banerjee brings AI, technology, and data transformation experience from leading data focused companies. The appointment comes as CoStar Group faces questions around transparency and reporting practices. For investors watching CoStar Group at a share price of $39.77, the appointment comes after a weak recent track record for the stock. The share price shows a 7.3% decline over the past week,...

NovoCure stock moves after recent performance shifts NovoCure (NVCR) is back on many investors’ screens after a recent stretch of weaker share performance, including negative returns over the past month, the past three months, and over the past year. See our latest analysis for NovoCure. The recent 1 day share price return of a 6.72% decline, adding to a 30 day share price return of a 19.75% decline and a 1 year total shareholder return of a 41.83% decline, suggests momentum has been fading...

DocuSign snapshot after recent share performance DocuSign (DOCU) has seen its share price move to US$45.71, with a return of about 1% over the past month and a decline of roughly 34% over the past 3 months. See our latest analysis for DocuSign. For context, DocuSign’s recent share price return shows short term stability but longer term pressure. The 30 day share price gain of 1.42% is set against a 1 year total shareholder return decline of 45.05% and a 5 year total shareholder return decline...

If you are wondering whether Uranium Energy's share price still offers value after a strong run, the key is to look past headlines and focus on what the numbers are saying about the business. The stock last closed at US$12.92, with returns of 6.9% over 7 days, a 15.7% decline over 30 days, a 1.4% decline year to date, and a 160.0% return over the last year. Recent attention on Uranium Energy has largely centered on its role in the uranium and nuclear fuel supply chain, along with broader...

Olive Garden, part of Darden Restaurants (NYSE:DRI), has introduced GLP-1-friendly and smaller portion menu options targeted at health-focused guests. The chain is also expanding its "Buy One, Take One" promotion to reinforce value perception and encourage repeat visits. These moves come as casual dining brands look for ways to support traffic in a competitive mid-scale segment. Darden Restaurants, trading around $192.49, sits in a mixed performance spot with a 36.8% return over 3 years and...

Freshpet stock under pressure after extended pullback Freshpet (FRPT) has come under renewed pressure, with the share price down about 5% in the past day, 13% over the past week, roughly 34% over the past month, and 11% in the past 3 months. See our latest analysis for Freshpet. At a share price of US$55.93, Freshpet’s recent pullback extends a weaker trend, with short term momentum fading and a 1 year total shareholder return decline of 33.72% underscoring how sentiment has shifted. If this...

Boeing recently confirmed major commercial aircraft deals, including up to 40 787 Dreamliners for Sun PhuQuoc Airways and 50 737 MAX jets for Vietnam Airlines, adding to its reported US$682.00 billion order backlog. These widebody and narrowbody commitments highlight how demand across both long- and short-haul fleets could influence Boeing's efforts to improve profitability and production consistency after weak core margins and reliance on one-off gains. Now we’ll examine how these...

Wondering whether Americold Realty Trust at around US$10.94 is starting to look like value, or if the recent weakness is a warning sign? This article breaks down what the current price might be implying. The stock has seen a 2.8% decline over the last week, an 18.3% decline over the last month, and is down 47.5% over the past year, with longer term 3-year and 5-year returns of 56.7% and 66.3% declines. This raises questions about how the market is reassessing its prospects and risks. Recent...

If you are wondering whether Central Garden & Pet is priced attractively at its recent US$37.02 close, the key question is how that tag compares with what the business may be worth. The stock has seen mixed recent returns, with a 5.2% gain over the last 7 days, a 5.5% decline over the past 30 days, and gains of 15.9% year to date and 3.0% over the last year, which can signal changing views on both potential and risk. Several company-focused headlines have kept Central Garden & Pet on...